The Architecture of Diagnostic Research

The Evidence Base of Clinical Diagnosis: Theory and methods of diagnostic research: Second Edition

Volumn , Issue , 2009, Pages 20-41

  Haynes, R Brian ^a,b   You, John J ^c,d  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

Answering a Phase II question; Answering a Phase III question with likelihood ratios; Architecture of diagnostic research; Limitation of Phase V studies; normal or Gaussian distribution; Putative diagnostic test or BNP; Target disorder and different test results; Threats to validity of Phase III studies; Validity of accuracy estimates generated in Phase III studies

Indexed keywords

EID: 80053473622     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300574.ch2     Document Type: Chapter

References (19)

1. Hobbs R. Can heart failure be diagnosed in primary care? BMJ. 2000;321:188-89.
2. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston: Little, Brown; 1991. pp. 58-61.
3. Murphy EA. The normal, and perils of the sylleptic argument. Perspect Biol Med. 1972;15:566.
4. Haynes RB, Harper AC, Costley SR, et al. Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial. J Hypertens. 1984;2:535.
5. Mencken HL. A Mencken chrestomathy. Westminster: Knopf; 1949. p. 12.
6. Talwar S, Siebenhofer A, Williams B, et al. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal pre-BNP. Heart. 2000;83:278-82.
7. Selvais PL, Donickier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure. Eur J Clin Invest. 1998;28:636-42.
8. Landray MJ, Lehman R, Arnold I. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. BMJ. 2000;320:985-86.
9. Wells PS, Hirsh J, Anderson DR, et al. A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process. J Intern Med. 1998;243:15-23.
10. McAlister FA, Straus SE, Sackett DL (On behalf of the CARE-COAD group). Why we need large, simple studies of the clinical examination: the problem and a proposed solution. Lancet. 1999;354:1721-24.
11. Straus SE, McAlister FA, Sackett DL, et al. The accuracy of patient history, wheezing, and laryngeal measurements in diagnosing obstructive airway disease. JAMA. 2000;283:1853-57.
12. Sackett DL, Straus SE, Richardson WS, et al. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Edinburgh: Churchill Livingstone; 2000. pp. 82-84.
13. Wright SP, Doughty RN, Pearl A, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial. J Am Coll Cardiol. 2003;42:1793-800.
14. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 1998(3):CD001216.
15. Cadman D, Chambers LW, Walter SD, et al. Evaluation of public health preschool child development screening: the process and outcomes of a community program. Am J Public Health. 1987;77:45-51.
16. Stone JH. Incidentalomas-clinical correlation and translational science required. N Engl J Med. 2006;354:2748-49.
17. Fisher ES,Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA. 1999;281:446-53.
18. Iglehart JK. The new era of medical imaging-progress and pitfalls. N Engl J Med. 2006;354:2822-28.
19. Mueller C, Laule-Kilian K, Schindler C, et al. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med. 2006;166:1081-87.